Home/Tarsier Pharma/Daphne Haim-Langford
DH

Daphne Haim-Langford

Founder & CEO

Tarsier Pharma

Therapeutic Areas

Tarsier Pharma Pipeline

DrugIndicationPhase
TRS01Non‑infectious anterior uveitis (including uveitic glaucoma)Phase 2
Tarsier-04Inflammatory ocular disease (specific indication undisclosed)Phase 3